Clinical Trial Update: A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind trial evaluating antroquinonol in chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Antroquinonol (antroquinonol)

Snippet

Sponsor: Golden Biotechnology Corporation | Conditions: HBV | Phase 2 | Status: COMPLETED